Drugs / CRH ferring®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02674256 Comparator | Mar → May 2014 | autoimmune disorder of gastrointestinal tract | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRH ferring | “100µg CRH powder for injection (CRH ferring®, Ferring, Aalst, Belgium) and 1 mL of NaCl 0.9% will be put together, then the solution will be injected intravenously over the...” NCT02674256 ↗ |
| Known as | CRH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02674256 ↗ |
| Route | Intravenous | “the solution will be injected intravenously over the course of 1 minute” NCT02674256 ↗ |